Insider Transactions in Q1 2026 at Guardant Health, Inc. (GH)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Terilyn J. Monroe Chief People Officer |
SELL
Open market or private sale
|
Direct |
10,031
-11.82%
|
$1,123,472
$112.6 P/Share
|
|
Jan 01
2026
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,392
-21.39%
|
$957,984
$102.14 P/Share
|
|
Jan 01
2026
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,237
+9.42%
|
-
|
|
Jan 01
2026
|
Terilyn J. Monroe Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,524
-19.52%
|
$767,448
$102.14 P/Share
|
|
Jan 01
2026
|
Terilyn J. Monroe Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,555
+17.89%
|
-
|
|
Jan 01
2026
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,989
-15.93%
|
$1,018,878
$102.14 P/Share
|
|
Jan 01
2026
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,046
+6.24%
|
-
|
|
Jan 01
2026
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,788
-0.52%
|
$1,100,376
$102.14 P/Share
|
|
Jan 01
2026
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+1.14%
|
-
|
|
Jan 01
2026
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,788
-0.53%
|
$1,100,376
$102.14 P/Share
|
|
Jan 01
2026
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,997
+1.17%
|
-
|
|
Jan 01
2026
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,479
-23.68%
|
$1,272,858
$102.14 P/Share
|
|
Jan 01
2026
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,038
+10.99%
|
-
|
|
Jan 01
2026
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,316
-41.41%
|
$1,256,232
$102.14 P/Share
|
|
Jan 01
2026
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,732
+17.0%
|
-
|
|
Jan 01
2026
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,522
-16.36%
|
$1,175,244
$102.14 P/Share
|
|
Jan 01
2026
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,442
+7.21%
|
-
|
|
Jan 01
2026
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,162
-18.81%
|
$1,036,524
$102.14 P/Share
|
|
Jan 01
2026
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,237
+10.02%
|
-
|